Hessekiel Jeffrey
Exelixis Inc · EVP
Hessekiel Jeffrey is listed in filings as EVP at Exelixis Inc. This profile follows SEC Form 4 activity through Mar 17, 2026, including sale activity. Recent filings connect the profile to Exelixis Inc (EXEL) and Cytokinetics, Incorporated - Common Stock (CYTK). The current snapshot covers public activity from Aug 9, 2024 to Mar 17, 2026. Reported amounts are shown as $2.1M to $515.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M80k shares | SellAug 7, 2024 | $25.97 | $55.55 | |
| $516k20k shares | SellAug 26, 2024 | $25.79 | $55.55 | |
| $660k25k shares | SellSep 23, 2024 | $26.38 | $55.55 | |
| $710k25k shares | SellOct 28, 2024 | $28.39 | $55.55 | |
| $2M50k shares | SellNov 1, 2024 | $34.13 | $55.55 | |
| $2M60k shares | SellNov 29, 2024 | $36.67 | $55.55 |